Literature DB >> 2463629

DNA sequences that mediate attenuation of transcription from the mouse protooncogene myc.

S Wright1, J M Bishop.   

Abstract

Expression of the protooncogene myc is regulated by multiple mechanisms and is probably involved in the control of cellular proliferation. Modulation of transcriptional elongation by attenuation within exon 1 of the myc gene is thought to play an important role in determining levels of myc RNA in both normal and tumor cells. We show that the first exon of mouse myc contains specific DNA sequences that may mediate transcriptional attenuation. A 180-nucleotide DNA fragment derived from the 3' end of exon 1 reduced transcriptional elongation by polymerase II when placed within an intron of the human alpha 1-globin gene and assayed by transfection into HeLa cells. A 36-nucleotide sequence that resembles a variety of transcriptional termination signals was located within this myc fragment but was by itself insufficient to cause attenuation when placed within the alpha-globin gene. Modulation of transcriptional elongation through specific DNA sequences within a gene may thus provide a mechanism for regulating its expression.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2463629      PMCID: PMC286499          DOI: 10.1073/pnas.86.2.505

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Removal of RNase activity from DNase by affinity chromatography on agarose coupled aminophenylphosphoryl-uridine-2' (3')-phosphate.

Authors:  I H Maxwell; F Maxwell; W E Hahn
Journal:  Nucleic Acids Res       Date:  1977-01       Impact factor: 16.971

2.  Purified RNA polymerase II recognizes specific termination sites during transcription in vitro.

Authors:  R L Dedrick; C M Kane; M J Chamberlin
Journal:  J Biol Chem       Date:  1987-07-05       Impact factor: 5.157

3.  An antitermination protein engages the elongating transcription apparatus at a promoter-proximal recognition site.

Authors:  S Barik; B Ghosh; W Whalen; D Lazinski; A Das
Journal:  Cell       Date:  1987-09-11       Impact factor: 41.582

4.  Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product.

Authors:  S Y Kao; A F Calman; P A Luciw; B M Peterlin
Journal:  Nature       Date:  1987 Dec 3-9       Impact factor: 49.962

Review 5.  Transcription attenuation.

Authors:  C Yanofsky
Journal:  J Biol Chem       Date:  1988-01-15       Impact factor: 5.157

6.  Regulation of c-fos gene expression in hamster fibroblasts: initiation and elongation of transcription and mRNA degradation.

Authors:  P Fort; J Rech; A Vie; M Piechaczyk; A Bonnieu; P Jeanteur; J M Blanchard
Journal:  Nucleic Acids Res       Date:  1987-07-24       Impact factor: 16.971

7.  Mutations in the first exon are associated with altered transcription of c-myc in Burkitt lymphoma.

Authors:  E Cesarman; R Dalla-Favera; D Bentley; M Groudine
Journal:  Science       Date:  1987-11-27       Impact factor: 47.728

8.  Specific inhibition of nuclear RNA polymerase II by alpha-amanitin.

Authors:  T J Lindell; F Weinberg; P W Morris; R G Roeder; W J Rutter
Journal:  Science       Date:  1970-10-23       Impact factor: 47.728

9.  Premature termination during adenovirus transcription.

Authors:  R Evans; J Weber; E Ziff; J E Darnell
Journal:  Nature       Date:  1979-03-22       Impact factor: 49.962

10.  Differential expression of c-myb mRNA in murine B lymphomas by a block to transcription elongation.

Authors:  T P Bender; C B Thompson; W M Kuehl
Journal:  Science       Date:  1987-09-18       Impact factor: 47.728

View more
  41 in total

1.  S-phase-specific expression of the Mad3 gene in proliferating and differentiating cells.

Authors:  E J Fox; S C Wright
Journal:  Biochem J       Date:  2001-10-15       Impact factor: 3.857

2.  Mad4 is regulated by a transcriptional repressor complex that contains Miz-1 and c-Myc.

Authors:  Louise Kime; Stephanie C Wright
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

3.  The transcriptional repressor gene Mad3 is a novel target for regulation by E2F1.

Authors:  Elizabeth J Fox; Stephanie C Wright
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

4.  cis-Acting Elements for Light Regulation of Pea Ferredoxin I Gene Expression Are Located within Transcribed Sequences.

Authors:  R. C. Elliott; L. F. Dickey; M. J. White; W. F. Thompson
Journal:  Plant Cell       Date:  1989-07       Impact factor: 11.277

5.  Deprivation of a single amino acid induces protein synthesis-dependent increases in c-jun, c-myc, and ornithine decarboxylase mRNAs in Chinese hamster ovary cells.

Authors:  P Pohjanpelto; E Hölttä
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

6.  A cis-acting element in the promoter region of the murine c-myc gene is necessary for transcriptional block.

Authors:  H Miller; C Asselin; D Dufort; J Q Yang; K Gupta; K B Marcu; A Nepveu
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

7.  Control of formation of two distinct classes of RNA polymerase II elongation complexes.

Authors:  N F Marshall; D H Price
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

8.  Analysis of premature termination in c-myc during transcription by RNA polymerase II in a HeLa nuclear extract.

Authors:  L London; R G Keene; R Landick
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

9.  Tyrosine kinase oncogenes abrogate interleukin-3 dependence of murine myeloid cells through signaling pathways involving c-myc: conditional regulation of c-myc transcription by temperature-sensitive v-abl.

Authors:  J L Cleveland; M Dean; N Rosenberg; J Y Wang; U R Rapp
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

10.  Loss of Marek's disease virus tumorigenicity is associated with truncation of RNAs transcribed within BamHI-H.

Authors:  G Bradley; G Lancz; A Tanaka; M Nonoyama
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.